A detailed history of Tower Research Capital LLC (Trc) transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 6,112 shares of ANIP stock, worth $331,025. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,112
Previous 1,959 212.0%
Holding current value
$331,025
Previous $124,000 193.55%
% of portfolio
0.01%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$54.33 - $65.72 $225,632 - $272,935
4,153 Added 212.0%
6,112 $364,000
Q2 2024

Aug 13, 2024

BUY
$58.53 - $68.82 $108,104 - $127,110
1,847 Added 1649.11%
1,959 $124,000
Q1 2024

May 15, 2024

SELL
$54.2 - $69.69 $237,396 - $305,242
-4,380 Reduced 97.51%
112 $7,000
Q4 2023

Feb 13, 2024

BUY
$48.72 - $65.43 $204,916 - $275,198
4,206 Added 1470.63%
4,492 $247,000
Q3 2023

Nov 14, 2023

SELL
$50.28 - $64.61 $6,234 - $8,011
-124 Reduced 30.24%
286 $16,000
Q2 2023

Aug 14, 2023

SELL
$37.29 - $53.83 $3,990 - $5,759
-107 Reduced 20.7%
410 $22,000
Q1 2023

May 09, 2023

BUY
$37.61 - $45.72 $8,537 - $10,378
227 Added 78.28%
517 $21,000
Q4 2022

Feb 10, 2023

SELL
$31.9 - $41.95 $80,483 - $105,839
-2,523 Reduced 89.69%
290 $12,000
Q3 2022

Nov 10, 2022

BUY
$29.83 - $38.01 $70,816 - $90,235
2,374 Added 540.77%
2,813 $91,000
Q2 2022

Aug 15, 2022

BUY
$23.09 - $33.46 $5,264 - $7,628
228 Added 108.06%
439 $13,000
Q1 2022

May 12, 2022

SELL
$26.91 - $47.15 $1,991 - $3,489
-74 Reduced 25.96%
211 $6,000
Q4 2021

Feb 14, 2022

SELL
$32.97 - $56.85 $21,067 - $36,327
-639 Reduced 69.16%
285 $13,000
Q3 2021

Nov 15, 2021

SELL
$26.48 - $35.99 $19,356 - $26,308
-731 Reduced 44.17%
924 $31,000
Q2 2021

Aug 16, 2021

BUY
$31.86 - $38.6 $36,129 - $43,772
1,134 Added 217.66%
1,655 $58,000
Q1 2021

May 17, 2021

SELL
$28.4 - $36.14 $15,534 - $19,768
-547 Reduced 51.22%
521 $19,000
Q4 2020

Feb 16, 2021

SELL
$23.69 - $31.47 $181,583 - $241,217
-7,665 Reduced 87.77%
1,068 $31,000
Q3 2020

Nov 16, 2020

BUY
$26.38 - $33.1 $188,142 - $236,069
7,132 Added 445.47%
8,733 $246,000
Q2 2020

Aug 13, 2020

BUY
$29.93 - $50.1 $47,917 - $80,210
1,601 New
1,601 $51,000
Q3 2019

Nov 05, 2019

SELL
$64.7 - $85.39 $24,909 - $32,875
-385 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$67.77 - $82.2 $26,091 - $31,647
385 New
385 $32,000
Q1 2019

May 14, 2019

SELL
$45.83 - $70.54 $11,503 - $17,705
-251 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$41.17 - $56.44 $10,333 - $14,166
251 New
251 $11,000
Q4 2017

Feb 09, 2018

SELL
$53.3 - $74.56 $27,236 - $38,100
-511 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$43.46 - $52.49 $22,208 - $26,822
511
511 $27,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $944M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.